Xcout Intel
miRecule, Inc. competitors & alternatives
The 12 closest competitors and alternatives to miRecule, Inc. among biotechnology companies — ranked by similarity to what miRecule, Inc. actually does, not by market-cap band.
Subscribe to see miRecule, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About miRecule, Inc.
miRecule, Inc. is a biotechnology company headquartered in Gaithersburg, Maryland, focused on developing RNA therapeutics.
miRecule, Inc. at a glance
miRecule, Inc. is a biotechnology company headquartered in United States. It has raised at least $12M across the 3 funding rounds on record. Its most recent funding round, Seed, raised $7M in May 2021. Xcout tracks 1 named person at miRecule, Inc., including Anthony Saleh (CEO).
miRecule, Inc. leadership
- Anthony SalehCEO
miRecule, Inc. funding rounds
At least $12M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $7M | 3 named | |
| Seed | $3.5M | 1 named | |
| SEC Form D filing | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 miRecule, Inc. competitors
Ranked by semantic similarity — how close each company is to miRecule, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Ceptur Therapeutics, Inc. is a private biotechnology company headquartered in Hillsborough, New Jersey, focused on developing targeted oligonucleotide therapeutics.
Similar biotechnology company
Georgiamune Inc. is a clinical-stage science and discovery biotechnology company headquartered in Gaithersburg, Maryland, operating within the BioHealth Capital Region.
Similar biotechnology company
Rgenta Therapeutics, Inc. is a biotechnology research company headquartered in Woburn, Massachusetts, that focuses on unlocking the therapeutic potential of disease-relevant RNA targets.
Biotech
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Similar biotechnology company
Mitotherapeutix, LLC is a biotechnology company that develops small interfering RNA (siRNA) based therapeutics targeting difficult disease pathways. The company focuses on modulating mitochondrial metabolic activity by inhibiting a negative gene regulator to treat a wide array of diseases.
Similar biotechnology company
Creyon Bio is a biotechnology organization that engineers RNA-based and oligonucleotide medicines designed to enable tissue-specific delivery with improved safety and efficacy.
Similar biotechnology company
InteRNA Technologies is a venture-backed biotech and life sciences company founded in 2008 and headquartered in Utrecht, Netherlands. The company specializes in the development of microRNA (miRNA)-focused drug pipelines and therapeutics. It operates within the biopharmaceutical sector, supported by various institutional backers and investors.
Similar biotechnology company
Remedy Plan, Inc. is a Maryland-based biotechnology holding company founded in 2011 that focuses on drug pipelines, patents, and clinical trials.
Biotech
Sirnaomics Ltd. is an RNA therapeutics biopharmaceutical company, founded in 2007 and headquartered in Gaithersburg, Maryland. The company is dedicated to identifying and developing innovative therapeutic compounds aimed at addressing significant medical needs across the United States and the People's Republic of China. Its leading pipeline assets include STP705, which is being investigated for conditions such as cutaneous squamous cell carcinoma in situ, basal cell carcinoma, various liver-related cancers (cholangiocarcinoma, hepatocellular carcinoma, liver metastases), as well as for keloid scar remodeling, hypertrophic scarring, and fat sculpting. Another prominent candidate, STP707, is designed to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, metastatic cutaneous squamous cell carcinoma, non-small cell lung cancer, and both liver and lung fibrosis. Beyond these lead programs, Sirnaomics is advancing STP355 for a range of cancers; STP369 for head and neck/bladder cancers; STP779 for liver, lung, and pancreatic cancers; and STP902 for breast cancer. The company's portfolio also extends to infectious diseases with STP702 for influenza, STP908 for COVID-19, the RIM730 COVID-19 vaccine, and STP909 for HPV/cervical cancer. Furthermore, its developmental pipeline encompasses STP122G for thrombotic disorders, STP125G for hypertriglyceridemia, STP144G for complement-mediated ailments, STP133G for cardiometabolic conditions, and STP155G for hepatitis B virus.
Similar biotechnology company
Arcellx, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to developing innovative immunotherapies and cell therapies for cancer patients.
Biotech
Orgenesis Inc. is a public biotechnology company founded in 2012. It has its primary headquarters located in Germantown, Maryland, United States.
Similar biotechnology company
Adaptive Phage Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, that is advancing the APT phage bank. The company focuses on developing phage-based therapeutics to address bacterial infections.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of miRecule, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for miRecule, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →